Human medicines European public assessment report (EPAR): Cuprior, trientine, Revision: 0, Authorised
Related Biotechnology, Pharmaceutical and Healthcare News
- Human medicines European public assessment report (EPAR): Ceprotin, human protein C, Revision: 11, Authorised
- Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Revision: 14, Authorised
- Human medicines European public assessment report (EPAR): Insuman, insulin human, Revision: 24, Authorised
- Human medicines European public assessment report (EPAR): Zinbryta, daclizumab, Revision: 5, Authorised
- Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Revision: 11, Authorised
Original Article: Human medicines European public assessment report (EPAR): Cuprior, trientine, Revision: 0, Authorised
NEXT ARTICLE
More From BioPortfolio on "Human medicines European public assessment report (EPAR): Cuprior, trientine, Revision: 0, Authorised"
